Abstract
In this article, we report a novel, rapid and facile synthesis of a series of azo coupled Ugi four-component reaction derivatives and its evaluation for biological activity. A general and straightforward approach towards the microwaveassisted synthesis was initiated by the condensation reaction to obtain compounds 5 (a-h) achieving 80-92% yields. The reactions were irradiated for 5-10 min in presence of fluorite catalyst. The resulting compounds were diazotized followed by coupling reaction to attain compounds 7 (a-h) with 65-74% yields. The synthesized compounds were characterized on the basis of 1H and 13C NMR, I.R, elemental analysis, and mass spectral data. All the synthesized derivatives 7 (a-h) were screened for their potential in vivo anti-inflammatory action against a reference drug, Diclofenac. These compounds were also screened for in vitro antimicrobial activity against a few Gram- positive and Gram-negative bacteria using reference antibiotics, Ampicillin and Streptomycin. The screening data revealed that compounds 7g and 7h possess potential antiinflammatory activity while compounds 7a, 7b, 7g and 7h show potent antimicrobial activity. Structural variations bring about new physical and biological properties. As a result, azo coupled Ugi-4CR derivatives in near future can be used as potent drugs for inflammation and bacterial infections.
Keywords: Anti-inflammatory, antimicrobial, azo dye, green synthesis, microwave, Ugi reaction.
Current Bioactive Compounds
Title:Pharmacological Assessment of Ugi Multicomponent Reaction: Rapid and Green Synthesis of Novel Biological Agents
Volume: 9 Issue: 4
Author(s): Ipsita Mohanram and Jyotsna Meshram
Affiliation:
Keywords: Anti-inflammatory, antimicrobial, azo dye, green synthesis, microwave, Ugi reaction.
Abstract: In this article, we report a novel, rapid and facile synthesis of a series of azo coupled Ugi four-component reaction derivatives and its evaluation for biological activity. A general and straightforward approach towards the microwaveassisted synthesis was initiated by the condensation reaction to obtain compounds 5 (a-h) achieving 80-92% yields. The reactions were irradiated for 5-10 min in presence of fluorite catalyst. The resulting compounds were diazotized followed by coupling reaction to attain compounds 7 (a-h) with 65-74% yields. The synthesized compounds were characterized on the basis of 1H and 13C NMR, I.R, elemental analysis, and mass spectral data. All the synthesized derivatives 7 (a-h) were screened for their potential in vivo anti-inflammatory action against a reference drug, Diclofenac. These compounds were also screened for in vitro antimicrobial activity against a few Gram- positive and Gram-negative bacteria using reference antibiotics, Ampicillin and Streptomycin. The screening data revealed that compounds 7g and 7h possess potential antiinflammatory activity while compounds 7a, 7b, 7g and 7h show potent antimicrobial activity. Structural variations bring about new physical and biological properties. As a result, azo coupled Ugi-4CR derivatives in near future can be used as potent drugs for inflammation and bacterial infections.
Export Options
About this article
Cite this article as:
Mohanram Ipsita and Meshram Jyotsna, Pharmacological Assessment of Ugi Multicomponent Reaction: Rapid and Green Synthesis of Novel Biological Agents, Current Bioactive Compounds 2013; 9 (4) . https://dx.doi.org/10.2174/1573407209666131227162333
DOI https://dx.doi.org/10.2174/1573407209666131227162333 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Natural Anticoagulant Proteins in the Regulation of Autoimmunity: Potential Role of Protein S
Current Pharmaceutical Design Genetic and Environmental Modifiers of Alzheimers Disease Phenotypes in the Mouse
Current Alzheimer Research Molecular and Cellular Activities of Vitamin E Analogues
Mini-Reviews in Medicinal Chemistry Oncolytic Virotherapy for Breast Cancer Treatment
Current Gene Therapy Update on the Evidence of Statin Treatment to Reduce Plaque Vulnerability
Drug Metabolism Letters Preterm Labour: An Overview of Current and Emerging Therapeutics
Current Medicinal Chemistry Vascular Disease: A New Progenitor Biology
Current Vascular Pharmacology Digital Ulcers in Systemic Sclerosis – Frequency, Subtype Distribution and Clinical Outcome
Current Rheumatology Reviews Roles of IL-6-gp130 Signaling in Vascular Inflammation
Current Cardiology Reviews Recent Trends in Nanotechnology-Based Drugs and Formulations for Targeted Therapeutic Delivery
Recent Patents on Inflammation & Allergy Drug Discovery TNF-α Inhibitors with Anti-Oxidative Stress Activity from Natural Products
Current Topics in Medicinal Chemistry Recent Approaches for Studying the Role of Glia
CNS & Neurological Disorders - Drug Targets STAT3 and Its Phosphorylation are Involved in HIV-1 Tat-Induced Transactivation of Glial Fibrillary Acidic Protein
Current HIV Research Meet Our Editorial Board Member
Current Cancer Drug Targets The Natural Flavonoid Naringenin Inhibits the Cell Growth of Wilms Tumor in Children by Suppressing TLR4/NF-κB Signaling
Anti-Cancer Agents in Medicinal Chemistry NF-κB, a Potential Therapeutic Target for the Treatment of Multiple Sclerosis
CNS & Neurological Disorders - Drug Targets The Function and Integrity of the Neurovascular Unit Rests Upon the Integration of the Vascular and Inflammatory Cell Systems
Current Neurovascular Research miRNA-146a Improves Immunomodulatory Effects of MSC-derived Exosomes in Rheumatoid Arthritis
Current Gene Therapy Antimicrobial Peptides: Mediators of Innate Immunity as Templates for the Development of Novel Anti-Infective and Immune Therapeutics
Current Pharmaceutical Design Inflammation in Atherosclerosis: A New Therapeutic Target
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents